ER+/HER2+ Metastatic Breast Cancer
1 بازدیدها
administrator
07/03/23
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
نظری یافت نشد